Back to 
BlackRock, Inc.
BlackRock, Inc.
STLN8 quarters
Position history for BlackRock, Inc.'s holdings in Starling Oncology, Inc.
BlackRock, Inc. holds 4.7M shares of STLN (Starling Oncology, Inc.), worth $25.8M as of 2026-Q2. The position was increased (+7.5% shares). STLN represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$25.8M
Current Shares
4.7M
Total Value Change
+$25.7M
Total Shares Change
+4.5M
Quarter-by-Quarter History
Other major holders of STLN: FMR LLC